Тиреоидные кардиомиопатии, контрастиндуцированные тиреопатии и нефропатии.
Диагностика, лечение, профилактика
Диссертация
У больных гипотиреозом без сопутствующей сердечно-сосудистой патологии по линейным' и объемным расчетным показателям ремоделирования отмечается тенденция к их увеличению, но достоверные различия по большинству параметров не обнаружены. Достоверные различия наблюдаются в уменьшении индекса относительной толщины стенок ЛЖ. Наиболее подверженные изменениям при ИБС показатели ремоделирования сердца… Читать ещё >
Список литературы
- Балаболкип М.И. Диабетология. М, Медицина 2000. стр 23−34.
- Балаболкин М.И. Юндокринология . 1998 М., с. 438−470
- Беленков Ю, Н, Савченко А. П., Матчин Ю, Г, Современные принципы коронарной ангиографии .// Сердце.- 2002.- Т. 1, № 6(6).-С. 265−268.
- Беленков Ю.Н. Дисфункция левого желудочка у больных ИБС. Современные методы диагностики, медикментозной и немедикаментозной коррекции. Русский медицинский журнал 2000№ 17 стр 65−68.
- Беленков Ю. Н., Мареев В. Ю. Сердечно-сосудистый континуум. Журнал Сердечная Недостаточность. 2002−3(1):7−11.
- Беленков Ю.Н., Мареев В. Ю., Агеев Ф. Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. М.: ГЭОТАР-Медиа, 2006. 432 с.
- Беленков Ю.Н., Мареев В. Ю., Агеев Ф. Т. Эпидемиологические исследования сердечной недостаточности: состояние вопроса. Журнал Consilium-Medicum. 2002−4(3): 15−21.
- Боднар П.Н., Сердце при сахарном диабете \ Проблемы эндокринологии, — 1987 -№ 4 стр 77−81.
- Бокерия Л.А., Ключников И.В., Ишемическое ремоделирование левого желудочка. Монография. Москва 2002. стр, 54−88
- М.Бузиашвили Ю. И. Ключников И.В., Иноземцева Е. В., Мамаев Х. К., Мелконян A.M., Коваленко O.A. Ишемическое ремоделирование левого желудочка (определение, патогенез, диагностика, медикаментозная и хирургическая коррекция) Кардиология. 2002. № 10. с 88−94
- Герасимов Г. А., Фадеев В. В., Свиреденко Н. Ю. и др. Йоддефицитные заболевания в России. Руководство. М. 2001.
- Герасимов Г. А. Питунина H.A. Йод и аутоиммунные заболевания щитовидной железы.// Проблемы эндокринологии 1989 № 1 стр, 44−45.
- Дедов И.И., Балаболкин М. И., Марова Е. И. Болезни органов эндокринной системы М. Медицина 2000 стр 78−81.
- Дедов И.И. Фадеев В.В., Введение в диабетологию М, Берег 1998 стр 137−138
- Дедов И. И. Шестакова М.В., Миленькая Т. М. Сахарный Диабет, ретинопатия. Нефропатия. М. Медицина 2001. 176, v- 175
- Дедов И. И. Шестакова М. В. Диабетическая нефропатия. М. Универсум Паблишинг 2000. стр 240−243.
- Иен П.М., Чин У. У. Молекулярные механизмы внутриядерного действия тиреоидных гормонов. В кн.: Болезни щитовидной железы. Л. И. Браверман (ред.). М.: Медицина, 2000- 1−2: 18.
- Кандрор В.И., Крюкова И. В., Антитироидные антитела и аутоиммунные заболевания щитовидной железы. Проблемы эндокринологии 1997 т 43 № 3 стр 25−30.
- Лейкок Д, Ф, Вайс П, Г, Основы эндокринологии пер с английского М, Медицина, 2000
- Панченкова Л, А" Трошина Е, В" Юркова Т, Н, и др, Особенности кардиологического статуса больных ИБС с наличием субклинического гипотиреоза. Компьютерная электрокардиография на рубеже столетий ХХ-ХХ, М.1999. С.39−41.
- Панченкова Л.А., Трошина Е. В., Юркова Т. Н., и др. Особенности кардиологического статуса больных ИБС с наличием субклинического гипотиреоза.// компьютерная электрокардиография на рубеже столетий М., XX-XXI. 1999. С.39−41.
- Пирс Э., Браверман Л. Субклинический тиреотоксикоз. Thyroid international 2001- стр 5−9.
- Потин В. В, Юхлова H.A. Бескровный С. В, Патология щитовидной железы. Проблемы эндокринологии 1989. № 1.&bdquo-С. 44−48.
- Практические рекомендации АССАНА комитета по коронарографии. Бюллетень НЦССХ им. А. Н. Бакулева РАМН том 3.№ 8 2002.стр 74−76.
- Роти Э. Браверманн Л, И. Заболевания щитовидной железы, индуцированные йодом ././ Болезни щитовидной железы./ под редакцией Л. И. Браверманна.- Медицина, 2000. С. 401−417,
- Синицин В.Е. Применение ионных рентген контрастных средств в современной лучевой диагностике. Вопросы клинической эффективности. Безопасности фармакоэкономики.// Мед. Визуализация.-2003 .-№ 1.-С. 121−126,
- Тугеева Э.Ф., Свириденко Н.ДО., Арипов М. А. и др. Влияние йодсодержащих рентгеноконтрастных препаратов на функциющитовидной железы у больных ИБС., Бюллетень НЦ ССХ им. А. Н. Бакулева РАМН том 6. № 2. 2005 стр 183−187.
- Фадеев В. В. Мельниченко Г. А., Герасимов Г, А. Аутоиммунный тиреоидит, Первый шаг к консенсусу.// Проблемы эндокринологии. 2001. Т. 47 № 4. С. 7−13'.
- Фомин И.В., Беленков Ю. Н., Мареев В. Ю., Агеев Ф. Т. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации данные ЭПОХА-ХСН. Журнал Сердечная Недостаточность. 2006−7(3): 112−115.
- Флетчер Р. Флетчер Ф. Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М. Медиа сфера, 1998. № 3. С. 52−54.
- Шестакова М.В., Дедов И. И., Мухин Н. А., Метаболические и гемодинамические аспекты диабетической нефропатии. Проблемы эндокринологии 1993 № 3 стр 55−57.
- Abrahmsen AM, Haarstad G, Oulie С 1963 Haemodynamic studies in thyrotoxicosis: before and after treatment. Acta Med Scand 174:463−467 American Heart Association. Heart Disease and Stroke Statistics. 2006 Update, p 35.
- Amidi M, Leon DF, DeGroot WJ, Kroetz FW, Leonard JJ 1968 Effect of the thyroid state on myocardial contractility and ventricular ejection rate in man. Circulation 38:229−239
- Andrade L., Campos S.B., Seguro A.C. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of arginine // Kidney1. t- 1998:53:173 6−1742.
- Anthonisen P, Hoist E, Thomsen AA 1960 Determination of cardiac output and other hemodynamic data in patients with hyper- and hypothyroidism, using dye dilution technique. Scand J Clin Lab Invest 12:472−480
- Aouate P., N. Elbaz, J. Tonet, D. Raguin, D. Klug, JL. Dubois-Rande 2, R. Frank Amiodarone-induced atrial flutter with 1:1 atrioventricular nodal conduction European Heart Journal 2003-Vol.24(Abstract Supplement):393
- Aspelin P., Aubry P., Fransson S.G. et al. Nephrotoxic effects in high-risk patients undergoing angiography // N Engl J Med 2003−348−491−499.
- Auer J., R. Berent, T. Weber, E. Lassnig, G. Lamm, E. Maurer, B. Eber. Thyroid function is associated with presence and severity of coronary atherosclerosis European Heart Journal 2003-Vol.24(Abstract Supplement) :43 5
- Auer J., R. Berent, T. Weber, E. Lassnig, G. Lamm, E. Maurer, B.
- Eber.Thyroid function is associated with presence and severity of coronaryatherosclerosis 6.0, pp 267−280. Chicago, Illinois: SPSS Inc., 1993.50.
- Bagshaw S.M., Ghali W.A. Teophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis // Arch Intern Med 2005−165:1087−1093.
- Barrett B.J., Parfrey P. S. Preventing nephropathy induced by contrast medium // N Engl J Med 2006−354:379−386.
- Bernadette BlONDI, EMILIANO A PALMIERI, GAETANO LOMBARDI, AND SERAFINO FAZIO, Effects of Thyroid Hormone on Cardiac Function: The
- Relative Importance of Heart Rate, Loading Conditions, and Myocardial Contractility in the Regulation of Cardiac Performance in Human Hyperthyroidism, J Clin Endocrinol Metab, March 2002, 87(3):968−974
- Bernardi L, Leuzzi S, Radaelli A, Passino C, Johnston JA Sleight P. Low-frequency spontaneous uctuations of R-R interval and blood pressure in conscious humans: a baroreceptor or central phenomenon? Clinical Science 1994. 87. 649- 654.
- Bilezikian JP, Loeb JN 1983 The influence of hyperthyroidism and hypothyroidismon and -adrenergic receptor systems and adrenergic responsiveness. Endocr Rev 4:378−388
- Biondi B, Fazio S, Carella C et al. Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term supressive therapy with levothyroxine. J Clin Endocrinol Metabol 1994- 78 (5): 1028−33.
- Biondi B, Fazio S, Cuocolo A et al. Impaired cardiac reserve and exercise capacity in patients receiving long term thyrotropin suppressive therapy with thyroxine. J Clin Endocrinol Metabol. 1996- 81: 4224−8.
- Biondi B, Palmeri EA, Fazio S et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metabol 2000- 85: 4701−5.
- Bonaduce D, Petretta M, lanniciello A, Apicella C, Cavallaro V Marciano F. Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction. American Journal of Cardiology 1997 79 p 564 569.
- Braunwald E, Sonnenblick EH, Ross Jr J 1992 Mechanisms of cardiac contraction and relaxation. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine, ed 4. Philadelphia: W.B. Saunders Company- 351 392
- Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaseth K, Castello R, Moghetti P, Muggeo M 1996 Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab 81:28 282 835
- Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaset K et al. Power spectral analysis of heart rate in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1996 81 p2828−2835.
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Int Med 2000- 160: 526−32.
- Cohen MV, Schulman IC, Spenillo A, Surks MI 1981 Effects of thyroid hormone on left ventricular function in patients treated for thyrotoxicosis. AmJCardiol 48:33−38
- Colan SD, Borow KM & Neumann A. The left ventricular endsystolic wall stress-velocity of ®ber shortening relation: a loadindependent index of myocardial contractility. Journal of the American College of Cardiology 1984 № 4 p715−724.
- Cooper DS. Subclinical thyroid disease: consensus or conundrum? Clin Endocrinol 2004- 60: 410−2.
- Crowley Jr WF, Ridgway EC, Bough EW, Francis GS, Daniels GFI, Kourides IA, Myers GS, Maloof F 1977 Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med 296:1−6
- Eur Heart J 2006, 27(Abstract Suppl), 492
- Dan G.-A., A. Dan, I. Daha, A. Buzea. Management of elderly with stroke and atrial fibrillation: the gap between guidelines and practice European Heart Journal 2004-Vol.25(Abstract Supplement):529
- Dangas G., Iakovou I., Nikolsky E., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables // Am J Cardiol 2005−95:13−19.
- DeGroot LJ 1972 Thyroid and the heart. Mayo Clin Proc 47:864−871
- DeGroot WJ, Leonard JJ 1970 Plyperthyroidism as a high cardiac output state. Am Heart J 79:265−275
- Detrenis S., Meschi M., Musini S. et al. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art // Nephrol Dial Transplant 2005−20:1542−1550.
- Devereux RB & Reicheck N. Echocardiographic determination of left ventricular mass in men. Circulation 1987 55 613±618.
- Dillmann WFI. Biochemical basis of thyroid hormone action in the heart. Am J Med 1990- 88: 626−30.
- DiPierro FV, Bavaria JE, Lankford EB, Polidori DJ, Acker MA, Streicher JT, Gardner TJ 1996 Triiodothyronine optimizes sheep ventriculoarterial coupling for work efficiency. Ann Thorac Surg 62:662−669
- Erbel R, Schweizer P, Krebs W, Langen HJ, Meyer J, Effert S 1984 Effects of heart rate changes on left ventricular volume and ejection fraction: a 2-dimensional echocardiographic study. Am J Cardiol 53:590−597
- Erley C.M. Does hydration prevent radiocontrast-induced acute renal failure? //Nephrol Dial Transplant 1999−14:1064−1066.
- Fadel BM, Ellahham S, Ringel MD, Lindsay J, Wartofsky L, BurmanKD Hyperthyroid heart disease. Clin Cardiol 2000 № 23:402−408
- Feldman T, Borow KM, Same DH, Neumann A, Lang RM 1986 Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7:967−974
- Fishbane S., Durham J.H., Marzo K. et al. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy // J Am Soc Nephrol 2004- 15:251 260.
- Folland ED, Parisi AF, Moghihan BS, Joney DR, Feldman CL Tow DE. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. Circulation 1979 60 p760−771.
- Forfar JC, Matthews DM, Toft AD 1984 Delayed recovery of left ventricular function after antithyroid treatment. Further evidence for reversible abnormalities of contractility in hyperthyroidism. Br Heart J 52:215−222
- Forfar JC, Muir AL, Sawers SA, Toft AD 1982 Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. N Engl J Med 307:1165−1170
- Friedman MJ, Okada RD, Ewy GA, Hellman DJ 1982 Left ventricular systolic and diastolic function in hyperthyroidism. Am Heart J 104:13 031 308
- G. Gheorghe, T. Nanea. Latent thyroid dysfunction in the elderly with persistent atrial fibrillation European Heart Journal 2005-Vol.26(Abstract Supplement): 73 6
- Galderisi M. JIaria Pietropaolo Aldo Celentano. Tissue Doppler identifies the degree of myocardial-diastolic dysfunction in chronic hypothyroidism. Italy European Fleart Journal 2001 volume 22 p 102.
- Gibson JG, Harris AW 1939 Clinical studies on the blood volume: V. Hyperthyroidism and myxedema. J Clin Invest 18:59−65
- Ginsberg AM 1931 The historical development of the present conception of cardiac conditions in exopthalmic goitre. Ann Intern Med 5:505−517
- Gleeson T.G., Bulugahapitiya S. Contrast-induced nephropathy // Am J Roentgenol 2004- 183:1673−1689.
- Goldenberg I., Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies // CMAJ 2005−172:1461−1471. .
- Gomberg-Maitland M & Frishman WH. Thyroid hormone and cardiovascular disease. American Fleart Journal 1998 135 187−196.
- Graettinger JS, Muenster JJ, Selverstone LA, Campbell JA 1959 A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. J Clin Invest 39:1316−1327
- Graves RJ 1835 Newly observed affectation of the thyroid gland in females. Lond Med Surg J 7:516−517
- Grossman W, Robin N1, Johnson LW, Brooks HL, Selenkow HA, Dexter L The enhanced myocardial contractility of thyrotoxicosis. Role of the adrenergic receptor. Ann Intern Med № 74, 1971:869−874
- Guray Y., U. Guray, H. Altay, M.B. Yilmaz, S. Cay, H. Kisacik, B. Mecit, S. Korkmaz. P wave duration and P wave dispersion in hyperthyroidism and risk of paroxysmal atrial fibrillation: efficacy of antithyroid treatment
- European Heart Journal 2004-Vol.25(Abstract Supplement):63
- Halapas A., P. Lembessis, C. Pantos, D.V. Cokkinos, M. Koutsilieris. Parathyroid hormone related protein mRNA expression after ischaemia and reperfusion in rat ventricular myocardium. European Heart Journal2005-'Vol, 26(Abstract Supplement) :607
- Hammond HK, White FC, Buxton ILO, Saltzstein P, Brunton LL Longhurst JC. Increased myocardial b-receptors and adrenergic responses in hyperthyroid pigs. American Journal of Physiology. Heart and Circulatory Physiology 1987 252 283.
- Heyman S.N., Brezis M., Epstein F.H. et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin // Kidney Int 1991−40:632−642.
- Heyman S.N., Goldfarb M., Shina A. et al. N-acetylcysteine ameliorates renal microcirculation: studies in rats // Kidney Int 2003−63:634−641.
- Heyman S.N., Rosenberger C., Rosen S. Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy // Nephrol Dial Transplant Suppl 2005−20:6−11.
- Hillis WS, Bremner WF, Lawrie TD, Thomson JA 1975 Systolic time intervals in thyroid disease. Clin Endocrinol (Oxf) 4:617−624
- Floit BD, Khoury SF, Shao Y, Gabel M, Liggett SB, Walsh RA 1997 Effects of thyroid hormone on cardiac -adrenergic responsiveness in conscious baboons. Circulation 96:592−598
- ITollowel JG, Staehling NW, Hannon WFI et al. Serum thyrotropin, thyroxine and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NITANES III). J Clin Endocrinol Metabol, in press.
- Flori M, Yeliin EL, Sonnenblick EH 1982 Left ventricular diastolic suction as a mechanism of ventricular filling. Jpn Circ J 46:124−129
- Ikram FI 1985 The nature and prognosis of thyrotoxic heart disease. Q J Med 54:19−28
- Islcandrian AS, Rose L, Hakki AFI, Segal BL, Kane SA 1983 Cardiac performance in thyrotoxicosis: analysis of 10 untreated patients. Am J Cardiol 51:349−352
- Jiang M, Xu A, Tokmakejian S & Narayanan N. Thyroid hormone-induced overexpression of functional ryanodine receptors in the rabbit heart. American Journal of Physiology. Heart and Circulatory Physiology 2000 278 p429−438.
- Kahaly G, Hellermann J, Mohr-Kahaly S, Trcese N. Impaired cardiopulmonary exercise capacity in patients with hyperthyroidism. Chest 1996- 109 (1): 57−61.
- Kahaly GJ, Wagner S, Nieswandt J, Mohr-Kahaly S, Ryan TJ 1999 Stress echocardiography in hyperthyroidism. J Clin Endocrinol Metab 84:2308−2313
- Kammoun I., T. Ben Chedly, I. Ghorbel, A. Ben Iialima, S. Ksadri, X. Belhadj, A. Lefi, S. Kachboura P-wave dispersion is a predictor of paroxysmal atrial fibrillation in hypertensive population
- European Heart Journal 2005-Vol.26(Abstract Supplement):733
- Kapitola J, Schullerova M, Vilimovska D 1979 Haemodynamic effects of propranolol in intact rats and in animals with artificial hyperthyroidism. Physiol Bohemoslov 28:347−355
- Kapitola J, Vilimovska D 1981 Inhibition of the early circulatory effects of triiodothyronine in rats by propranolol. Physiol Bohemoslov 30:347−351
- Katzberg R.W., Morris T.W., Burgener F.A. et al. Renal rennin and haemodynamic responses to selective renal artery catheterization and angiography // Invest Radiol 1977−12:381−388.
- ICimura Y, Otsu K, Nishida K, Kuzuya T & Tada M. Thyroid hormone enhances Ca2+ ATPase and decreasing phospholamban expression. Journal of Molecular and Cellular Cardiology 1994 26 pi 1 451 154.
- Kiss E, Jakab G, Kranias EG & Edes I. Thyroid hormone-induced alterations in phosholamban protein expression: regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circulation Research 1994 75 p245−251.
- Klein I & Ojamaa K. Thyroid hormone and the cardiovascular system. New England Journal of Medicine 2001 344 501 ±509.
- Klein I 1990 Thyroid hormone and the cardiovascular system. Am J Med 88:631−637
- Klein I, Levey GS 1984 Unusual manifestations of hypothyroidism. Arch Intern Med 144:123−128
- Klein I, Ojamaa K 1998 Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 27:51−62,
- Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501−509
- Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, IsomOW, Krieger K 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1562−1563
- Komiya N., S. Seto, R. Sibata, Y. Doi, S. Fukae, K. Nakao, S. Isomoto, K. Yano. Prolonged effective refractory period and maximal conduction delay in idiopathic atrial fibrillation with low T3 syndrome: a new entity in idiopathic atrial fibrillation?
- Koutras DA. Subclinical hyperthyroidism. Thyroid 1999- 9: 311−5.
- L.E.Braverman, O. Eber, W. Langsteger (eds.). Wien: 1994- 203. Polikar R, Feld GK, Dittrich HC et al. Effect of thyroid replacement therapy on the frequency of benigh atrial and ventricular arrythmias. J Am Coil Cardiol 1989- 14: 999−1002.
- Ladenson PW 1990 Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 88:638−641
- Lautin E.M., Freeman N.J., Schoenfeld A.Ii. et al. Radiocontrast-associated renal dysfunction: incidence and risk factors // Am J Roentgenol 1991−157:49−58.
- Leak D, Lew M 1962 Effect of treatment of hypothyroidism on circulatory response to adrenaline catecholamine. Br Med J 25:30−34
- Leese GP, Jung RT, Guthrie C et al. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those supressed TSFI. Clin Endocrinol (Oxf) 1992- 37: 500−3.
- LEO C. KUM, JWH. Fung, WY. So, WL. Chan, KAM S. Woo, CM. Yu, JE. Sanderson Prediction of amiodarone-induced thyroid dysfunction in those with normal baseline thyroid function: a retrospective analysis of 288 patients
- European Heart Journal 2003-Vol.24(Abstract Supplemental6
- Levey GS & Klein I. Catecholamine thyroid hormone interactions and the cardiovascular manifestation of hyperthyroidism. American Journal of Medicine 1990 88 642−646.
- Levey GS, Klein I 1990 Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 88:642−646
- Levine SA, Sturgis CC 1924 Hyperthyroidism masked as heart disease. Boston Med Surg J 190:233−237
- Lewis BS, Ehrenfeld EN, Lewis N, Gotsman MS 1979 Echocardiographic LV function in thyrotoxicosis. Am Heart J 97:460−468
- Liang YL, Gatzka CD, Du XJ, Cameron JD, Kingwell BA, Dart AM 1999 Effects of heart rate on arterial compliance in men. Clin Exp Pharmacol Physiol 26:342−346
- Liggett SB, Shah SD, Cryer PE 1989 Increased fat and skeletal muscle adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis. J Clin Invest 83:803−309
- Maciel CB, Gallo L Jr, Marin Neto JA, Maciel LMZ, Alves MLD, Paccola GMF et al. The role of the autonomic nervous system in the resting tachycardia of human hyperthyroidism. Clinical Science 1987 72 p239−244.
- Machill K, Scholz GH. Dependence of haemodynamic changes in hypothyroidism on age of patients and etiology hyperthyroidism. Heart and thyroid.
- Maeder M., Klein M., Fehr T., Rickli H. Contrast nephropathy- review focusing on prevention // J Am Coll Cardiol 2004−44- 1763−1771.
- Manske C.L., Sprafka J.M., Strony J.T., Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography //Am J Med 1990−89:615−620.
- Marenzi G., Lauri G., Assanelli E., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction // J Am Coll Cardiol 2004−44:1780−1785.
- Martin III WH, Spina RJ, Korte E 1992 Effect of hyperthyroidism of short duration on cardiac sensitivity to -adrenergic stimulation. J Am Coll Cardiol 19:1185−1191
- Matsukawa T, Mano T, Gotoh E, Minamisawa K & Ishii M. Altered muscle sympathetic nerve activity in hyperthyroidism and hypothyroidism. Journal of the Autonomic Nervous System 1993 23. 207−211.
- McCullough P.A., Wolyn R., Rocher L.L., et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality // Am J Med 1997−103:368−375.
- McDevitt DG, Riddell JG, Hadden DR, Montgomery DA 1978 Catecholamine sensitivity in hyperthyroidism and hypothyroidism. Br J Clin Pharmacol :297−3 01
- Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation // J Am Coll Cardiol 2004−44:1393−1399.
- Merillon JP, Passa P, Chastre J, Wolf A, Gourgon R 1981 Left ventricular function and hyperthyroidism. Br Heart J 46:137−143
- Minczykowslci A., K. Ziemnicka, J. Sowinski, H. Wysocki. Effect of thyroid hormones on cardiac performance estimated by tissue Doppler echocardiographyPoland2006 Eur Heart J 2006, 27(Abstract Suppl), 979
- Mintz G, Pizzarello R & Klein I. Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response totreatment. Journal of Clinical Endocrinology and Metabolism 1991 73 pi 46 150.
- Morlcin E. Regulation of myosin heavy chain genes in the heart. Circulation 1993 87 p 1451−1460.
- Nakatani S, Beppu S, Nagata S, Ishikura F, Tamai J, Yamagishi M, Ohmori F, Kimura K, Takamiya M, Miyatake K 1994 Diastolic suction in the human ventricle: observation during balloon mitral valvuloplasty with a single balloon. Am Pleart J 127:143−147
- Nash K., ITafeez A., Hou S. Hospital-acquired renal insufficiency // Am J Kidney Dis 2002−39:930−936.
- Nikolslcy E., Mehran R., lasic Z. et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions // Kidney Int 2005−67:706−713.
- Nixon JV, Anderson RJ, Cohen ML 1979 Alterations in left ventricular mass and performance in patients treated effectively for thyrotoxicosis. A comparative echocardiographic study. Am J Med 67:268 276
- Nordyke RA, Gilbert Jr FI, Harada AS 1988 Graves' disease. Influence of age on clinical findings. Arch Intern Med 148:626−631
- Norusis, MJ. SPSS for Windows. Base System User’s Guide. Release
- Ojamaa K, Klein I, Sabet A, Steinberg SF 2000 Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac adrenergic receptor responsiveness. Metabolism 49:275−279
- Ojamaa K, Klemperer JD, Klein I 1996 Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6:505−512
- Ojamaa K, Klemperer JD, MacGilvray SS, Klein I. Samarel A. Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology 1996 137 p802−808.
- Osman F., J. Daykin, S. Chowdhary, M. Sheppard, JA. Franklyn. The cardiac autonomic function in hyperthyroidism before and after effective anti-thyroid therapy. European Heart Journal 2003-Vol.24(Abstract Supplement): 157
- Osman F., J.A. Franklyn, M.C. Sheppard, M.D. Gammage Cardiac dysrhythmias in hyperthyroidism before, during and after effective antithyroid therapy. European Heart Journal 2005-Vol.26(Abstract Supplement) :3 75
- Osman F., J.A. Franklyn, M.C. Sheppard, M.D. Gammage Cardiovascular consequences of hyperthyroidism before, during and after antithyroid treatment European Heart Journal 2005-Vol.26(Abstract Supplement) :611
- Pannu N., Wiebe N., Tonelli M. Prophylaxis strategies for contrast-induced nephropathy // JAMA 2006−295:2765−2779.
- Pantos C., I. Mourouzis, I. Paizis, S. Tzeis, P. Moraitis, K.
- Sfakianoudis, D. Varonos, D.V. Cokkinos. Blockade of thyroid hormone nuclear receptor alpha 1 by dronedarone increases the tolerance of the isolated rat heart to ischaemia-reperfusion injury European Heart Journal 2004-Vol.25(Abstract Supplement):339
- Parisi AF, Hamilton BP, Thomas CN, Mazzaferri EL 1974 The short cardiac pre-ejection period: an index to thyrotoxicosis. Circulation 49:900 904
- Parisi AF, Flamilton BP, Thomas CN. Mazzaferri EL. The short cardiac pre-ejection period. An index of thyrotoxicosis. Circulation 1974W 49 p 900−904.
- Parle JV, Maisonneuve P, Sheppard MS et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001- 358: 861−5.
- Parry CH 1825 Collections from the unpublished papers in the Caleb Hilled Parry. Dis Heart 2:111−165
- Paul W, Ladenson MD. Editorial: Thyrotoxicosis and the Heart: Something Old and Something New. Devision of Endocrinology and Metabolism 1993.
- Perlstein T.S., Gumieniak O., Hopkins P.N. et al. uric acid and the state of the intrarenal renin-angiotensin system in humans // Kidney Int 2004−66:1465−1470.
- Pfluger A., Larson T.S., Nath K.A. et al. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus // Mayo Clin Proc 2000−75:1275−1283.
- Polikar R, Burger AG, Scherrer U, Nicod P 1993 The thyroid and the heart. Circulation 87:1435−1441
- Pomeranz B, MacAulay RJB, Caudill MA, Kutz I, Adam D, Gordon D et al. Assesment of autonomic function in humans by heart rate spectral analysis. American Journal of Physiology. Heart and Circulatory Physiology 1985 248 p 151−153.
- Resnick LM, Laragh JH 1982 Plasma renin activity in syndromes of thyroid hormone excess and deficiency. Life Sci 30:585−586
- Rothfeld JM, LeWinter MM, TishlerMD 1998 Left ventricular systolic torsion and early diastolic filling by echocardiography in normal humans. Am J Cardiol 81:1465−1469
- Rowe GG, Huston JH, Weinstein AB, Tuchman H, Brown JF, Crumpton CW 1956 The hemodynamics of thyrotoxicosis in man withspecial reference tocoronary blood flow and myocardial oxygen metabolism. J Clin Invest 35:272−276
- Rudnick M.R., Berns J.S., Cohen R.M. et al. Contrast media-associated nephrotoxicity // Semin Nephrol 1997−17:15−26.
- Rudnick M.R., Goldfarb S., Wexler L., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trail // The Iohexol Cooperative Study. 1995−47:254−261.
- Sa Cunha R, Pannier B, Benetos A, Siehe JP, London GM, Mallion JM, Safar ME 1997 Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 15:14 231 430
- Safa-Tisseront V, Ponchon P, Laude D & Elghozi JL. Autonomic contribution to the blood pressure and heart rate variability changes in early experimental hyperthyroidism. Journal of Hypertension 1998 16 pi 9 891 992.
- Samuels MN. Subclinical thyroid disease in the elderly. Thyroid 1998- 8: 803−13.
- Sandler G, Wilson GM 1959 The nature and prognosis of heart disease in thyrotoxicosis. Q J Med 28:247−269
- Sawin CT, Geller A, Wolf PA et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New Engl J Med 1994- 331: 1249−52.
- Sawin CT, Geller A, Wolf PA, Baker E, Bacharach P, Wilson P W et al. Low serum thyrotropin concentrations as a risk factor for atrialiibrillation in older persons. New England Journal of Medicine 1994 331 1249−1252.
- Schaefer S, Taylor AL, Lee ITR, Niggemann EH, Levine BD, Popma JJ, Mitchell JIT, ITillis LD 1988 Effect of increasing heart rate on left ventricular performance in patients with normal cardiac function. Am J Cardiol 61:617−620
- Sgarbi JA, Villaca F, Scandiuzzi S et al. Improvement of cardiac effects of endogenous subclinical hyperthyroidism with methimazol treatment (Abstract). 12th International Thyroid Congress. Kyoto 2000. Endocr J 2000- 47 (Suppl.): 179.
- Shafer RB, Bianco JA 1980 Assessment of cardiac reserve in patients with hyperthyroidism. Chest 78:269−273
- Shapiro LE, Sievert R, Ong L et al. Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin -suppressive doses of L-thyroxine. J Clin Endocrinol Metabol 1997- 82: 2592−5.
- Singh PI, Sood S, Sood AK 1986 Left ventricular diastolic function in hyperthyroid and hypothyroid states. J Assoc Physicians India 34:845−847
- Smallridge RC, Goldman MH, Raines K, Jones S, Van Nostrand D 1987 Rest and exercise left ventricular ejection fraction before and after therapy in young adults with hyperthyroidism and hypothyroidism. Am J Cardiol 60:929−931
- Solomon R. The role of osmolality in incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients // Kidney Int 2005−68:2256−2263.
- Spirilo B, Maron BJ Bonow R. Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. Journal of the American College of Cardiology 1986 7 p 518−526.
- Sterner G., Frennby B., Kurlcus K. et al. Does post-angiographic hemodialysis reduce the risk of contrast medium nephropathy? // Scand J Urol Nephrol 2000−34:323−326.
- Streeten DH, Anderson Jr GFI, Flowland T, Chiang R, Smulyan H Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 1988 № 1 l: p78−83
- Sultan K. R., B. Plenkel, H.-J. Seitz. Thyroid hormone receptors in the heart: chamber specific patterns and T3 responsive cardiac fibroblasts European Heart Journal 2003-Vol.24(Abstract Supplement):343.
- Summers VK, Surtees SJ 1961 Thyrotoxicosis and heart disease Acta Med Scand 169:661−671
- Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA 2001
- Surks MI, Ortiz E, Daniels G et al. Subclinical Thyroid Disease. JAMA 2004- 291: 228−38.
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996 93 pi043−1065.
- Tenerz A, Forberg R, Jansson R. Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med 1990- 228: 229−33.
- Theilen EO, Wilson WR 1967 Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. J Appl Physiol 22:207 210
- Thomsen H.S., Morcos S.K. ESUR Contrast Media Safety Committee. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media // Eur Radiol 1999−9:738−740.
- Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol 33:811−824
- Toft AD, Boon NA 2000 Thyroid disease and the heart. Heart 84:45 5460
- Toft AD. Subclinical hyperthyroidism. New Engl J Med 2001- 345: 512−6.
- Toft AD. Thyroxine therapy. New Engl J Med 1994- 331: 174−80.
- Toprak O., Cirit M. Risk factors contrast-induced nephropathy // Kidney Blood Press Res 2006−29:84−93.
- Toprak O., Cirit M., Yesil M. et al. Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment // Kidney Blood Press Res 2006−29:2−9.
- Tribulova N., H. Hailin, I. Imanaga Diabetes and thyroid hormones affect intercellular gap junction coupling in the rat heart ventricles Eur Heart J 2006, 27(Abstract Suppl), 198
- Tribulova N., H. Lin, I. Imanaga Diabetes as well as thyroid hormones affect intercellular gap junction coupling in the atria European Heart Journal 2004-Vol.25(Abstract Supplement):478
- Tunbrige WMG, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977- 7:481.93.
- Udelson JE, Bacharach SL, Cannon III RO, Bonow RO 1990 Minimum left ventricular pressure during -adrenergic stimulation in human subjects. Evidence for elastic recoil and diastolic «suction» in the normal heart. Circulation 82:1174−1182
- Utiger RD. Subclinical hyperthyroidism just a low serum thyrotrophin concentration, or something more? New Engl J Med 1994- 331: 1302−3.
- Uzan L., L. Guignat, S. Weber, X. Bertagna, P. Thomopoulos, D. Duboc. Continuation of treatment despite the development of type-II amiodarone-induced thyrotoxicosis: a therapeutic challenge European Heart Journal 2004-Vol.25(Abstract Supplement):491
- Weber KT, Janicki JS, Hunter WC, Shroff S, Pearlman ES, Fishman AP 1982 The contractile behavior of the heart and its functional coupling to the circulation. Prog Cardiovasc Dis 24:375−400
- Weinrauch L.A., Healy R.W., Leland O.S. et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy // Ann Intern Med 1977−86:56−59.
- Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ 2000 The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263−270
- Woeber KA Thyrotoxicosis and the heart. N Engl J Med 1992, 327:94−98